Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ANTITHYMOCYTE IMMUNOGLOBULIN: 81 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
81
Total FAERS Reports
39 (48.1%)
Deaths Reported
10
Hospitalizations
81
As Primary/Secondary Suspect
1
Life-Threatening
1
Disabilities

First Report: 199904 · Latest Report: 20131219

What Are the Most Common ANTITHYMOCYTE IMMUNOGLOBULIN Side Effects?

#1 Most Reported
Acute graft versus host disease
22 reports (27.2%)
#2 Most Reported
Autoimmune haemolytic anaemia
12 reports (14.8%)
#3 Most Reported
Therapeutic response decreased
10 reports (12.3%)

All ANTITHYMOCYTE IMMUNOGLOBULIN Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Acute graft versus host disease 22 27.2% 9 0
Autoimmune haemolytic anaemia 12 14.8% 1 0
Acute lymphocytic leukaemia recurrent 10 12.4% 8 0
Chronic graft versus host disease 10 12.4% 3 0
Drug ineffective 10 12.4% 8 1
Graft versus host disease 10 12.4% 7 1
Therapeutic response decreased 10 12.4% 1 0
Thrombocytopenia 6 7.4% 2 0
Acute myeloid leukaemia recurrent 5 6.2% 5 0
Epstein-barr virus infection 5 6.2% 0 1
Post transplant lymphoproliferative disorder 5 6.2% 3 0

Who Reports ANTITHYMOCYTE IMMUNOGLOBULIN Side Effects? Age & Gender Data

Average age: 30.7 years. Most reports from: CN. View detailed demographics →

Is ANTITHYMOCYTE IMMUNOGLOBULIN Getting Safer? Reports by Year

YearReportsDeathsHosp.
2011 1 1 0
2013 4 0 3

View full timeline →

What Is ANTITHYMOCYTE IMMUNOGLOBULIN Used For?

IndicationReports
Prophylaxis against graft versus host disease 38
Stem cell transplant 12
Bone marrow conditioning regimen 8
Aplastic anaemia 5
Immunosuppression 5

Official FDA Label for ANTITHYMOCYTE IMMUNOGLOBULIN

Official prescribing information from the FDA-approved drug label.